CD2.AX down 42% to A$0.49 on ASX 30 Jan 2026: what investors should watch
CD2.AX stock fell 42% to A$0.49 on ASX 30 Jan 2026; analysis, Meyka AI grade and forecast for traders
CD2.AX stock fell 42% to A$0.49 on ASX 30 Jan 2026; analysis, Meyka AI grade and forecast for traders
Meta stock price jumps after Q4 beat and bold 2026 AI capex plan of $115–$135B. What it means for Japan-based investors, with valuation, technicals, and key dates.
HLXW stock plunged 99% to $0.000001 on PNK; analysis of drivers, metrics, Meyka Grade and forecast
IDEA.BO stock intraday: trading INR 9.94 with 47.49M volume on BSE; Meyka grade, technicals and forecast
Pre-market update on 3SAR.PA stock: price €0.56, volume 641 on EURONEXT Jan 2026. Short-term technicals and Meyka AI forecast.
Pre-market ORCL.SW stock at CHF160.19 on 30 Jan 2026; analysis, Meyka grade and 1/3/5-year forecasts for ORCL.SW stock
MSFT stock dips as investors weigh softer Azure growth and a jump to $37.5B in AI capex. We unpack earnings, margins, and HK-focused takeaways, plus key technical levels.
8279.T stock jumps after hours to JPY 9,644.00 on JPX; Meyka AI forecast shows ~15.03% upside to JPY 11,093.83
Intraday coverage of 0277.HK stock down -12.50% on 30 Jan 2026 with Meyka AI analysis and forecast
Pre-market earnings preview for 5LA1.F stock on XETRA. Key metrics, Meyka grade and a 0.49 EUR forecast vs current EUR 0.545